Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-07-02)
Due Date
July 02, 2025
Grace Period Ends
January 02, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 17, 2025 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | Loading... |
| May 17, 2025 | C75A | O | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | Loading... |
| May 5, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jan 3, 2025 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED | Loading... |
| Jul 2, 2024 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Oct 25, 2019 | FINV | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Oct 9, 2019 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Oct 8, 2019 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Oct 2, 2019 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jul 2, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 16, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 16, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 27, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 2, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 1, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 26, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 25, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 25, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 19, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 19, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 9, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Feb 9, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Feb 3, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Feb 2, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 29, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 22, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jan 17, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 11, 2019 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Jan 3, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; ] pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; [ pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; ] pharmaceutical preparations for ophthalmological use; [ pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]
Additional Information
Design Mark
The mark consists of four sets of three-dimensional shaded rectangles with rounded sides displayed across from each other.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005